|Table of Contents|

Protective effect and mechanism of ecdysone on cisplatin induced liver injury in mice

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 02
Page:
241-248
Research Field:
Publishing date:

Info

Title:
Protective effect and mechanism of ecdysone on cisplatin induced liver injury in mice
Author(s):
YIN QianYUAN QinCHEN XiangyuCAI Xiaoming
College of Basic Medicine and Forensic Medicine,North Sichuan Medical University,Sichuan Nanchong 637000,China.
Keywords:
ecdysonecisplatinoxidative stressPDK1Dnmt3bMEK5
PACS:
R730.2
DOI:
10.3969/j.issn.1672-4992.2023.02.008
Abstract:
Objective:To investigate the protective effect and mechanism of ecdysone on cisplatin induced liver injury in mice.Methods:Kunming mice and AML12 cells were used to construct cisplatin induced liver injury model in vivo and in vitro.Ecdysone was used to intervene cisplatin group.The pathological morphology of liver tissue was observed by HE staining,the production of intracellular reactive oxygen and apoptosis were observed by ELISA and fluorescence staining,and the expressions of biomarkers related to oxidative stress,inflammation and apoptosis were detected by RT-qPCR.The target was determined by transcriptome sequencing,RT-qPCR and Western blot were used to verify the target genes' expressions of mRNA and protein.Results:Compared with the blank group,the hepatocytes in cisplatin group were loosely arranged,some cells were slightly swollen.The contents of ALT and AST in serum,ROS and MDA in cells increased significantly.And the contents of GSH-PX and SOD in cells decreased significantly,suggesting that cisplatin caused obvious damage to liver function.Compared with cisplatin group,the degree of hepatocyte injury in ecdysone group was significantly reduced,and the above indexes were improved in varying degrees,indicating that ecdysone had a protective effect on liver function.The results of RT-qPCR showed that,in ecdysone group,the mRNA expressions of NF-κB,TNF-α,IL-1β,Caspase-3,Caspase-9,Hmox1,PI3K,Nqo1 decreased significantly and Nrf2 increased(P<0.01).Transcriptome sequencing and validation experiments showed that ecdysone protects liver function by regulating the low expressions of PDK1 and the high expressions of Dnmt3b and MEK5.Conclusion:Ecdysone has a protective effect on cisplatin induced liver injury through the synergistic regulation of inflammation,oxidative stress and apoptosis.And directly affect the expressions of Dnmt3b,MEK5 and PDK1,which may have a protective effect on liver injury caused by cisplatin.

References:

[1] GHOSH S.Cisplatin:The first metal based anticancer drug[J].Bioorg Chem,2019,88:102925.
[2] EL SI,ABDEL-LATIF GA,FARAG DB,et al.Ameliorative effect of betanin on experimental cisplatin-induced liver injury;the novel impact of miRNA-34a on the SIRT1/PGC-1α signaling pathway[J].J Biochem Mol Toxicol,2021,35(6):1-14.
[3] TAN X,ZHOU Y,AGARWAL A,et al.Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect[J].Am J Cancer Res,2020,10(12):4416-4434.
[4] ZHENG Z,MA Y,WANG L,et al.Chinese herbal medicine Feiyanning cooperates with cisplatin to enhance cytotoxicity to non-small-cell lung cancer by inhibiting protective autophagy[J].J Ethnopharmacol,2021,276:114196.
[5] LU X,DENG T,DONG H,et al.Novel application of eupatilin for effectively attenuating cisplatin-induced auditory hair cell death via mitochondrial apoptosis pathway[J/OL].Oxid Med Cell Longev,2022,2022:1090034[2022-03-30].https://doi.org/10.1155/2022/1090034.
[6] HU B,LIU Y,CHEN X,et al.Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo[J].Biochem Biophys Res Commun,2020,533(4):1442-1448.
[7] DASARI VR,CAREY DJ,GOGOI R.Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells[J].BMC Cancer,2020,20(1):273.
[8] DINAN L,DIOH W,VEILLET S,et al.20-hydroxyecdysone,from plant extracts to clinical use:therapeutic potential for the treatment of neuromuscular,cardio-metabolic and respiratory diseases[J].Biomedicines,2021,9(5):492.
[9] MALLEK A,MOVASSAT J,AMEDDAH S,et al.Experimental diabetes induced by streptozotocin in the desert gerbil,gerbillus gerbillus,and the effects of short-term 20-hydroxyecdysone administration[J].Biomed Pharmacother,2018,102:354-361.
[10] SBUNIAM J,CHUKIJRUNGROAT N,RATTANAVICHIT Y,et al.20-hydroxyecdysone ameliorates metabolic and cardiovascular dysfunction in high-fat-high-fructose-fed ovariectomized rats[J].BMC Complement Med Ther,2020,20(1):140.
[11] RIESWIJK L,LIZARRAGA D,BRAUERS KJ,et al.Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes,HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks[J].Mutagenesis,2014,29(1):17-26.
[12] SANTOS N,FERREIRA RS,SANTOS ACD.Overview of cisplatin-induced neurotoxicity and ototoxicity,and the protective agents[J].Food Chem Toxicol,2020,136:111079.
[13] WANG Y,HU PC,GAO FF,et al.The protective effect of curcumin on hepatotoxicity and ultrastructural damage induced by cisplatin[J].Ultrastruct Pathol,2014,38(5):358-362.
[14] HAMZEH M,HOSSEINIMEHR SJ,KHALATBARY AR,et al.Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model[J].Res Pharm Sci,2018,13(5):440-449.
[15] CHEN Y,ZHAO C,LIU X,et al.Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-κB signaling pathway in vitro and in vivo[J].Biomed Pharmacother,2019,116:108923.
[16] ZHAO K,WEN LB.DMF attenuates cisplatin-induced kidney injury via activating Nrf2 signaling pathway and inhibiting NF-κB signaling pathway[J].Eur Rev Med Pharmacol Sci,2018,22(24):8924-8931.
[17] YOON JH,YOUN K,JUN M.Protective effect of sargahydroquinoic acid against Aβ(25-35)-evoked damage via PI3K/Akt mediated Nrf2 antioxidant defense system[J].Biomed Pharmacother,2021,144:112271.
[18] VASHI R,PATEL BM.NRF2 in cardiovascular diseases:a ray of hope[J].J Cardiovasc Transl Res,2021,14(3):573-586.
[19] MISHRA V,BANGA J,SILVEYRA P.Oxidative stress and cellular pathways of asthma and inflammation:Therapeutic strategies and pharmacological targets[J].Pharmacol Ther,2018,181:169-182.
[20] IVANOV AV,VALUEV-ELLISTON VT,TYURINA DA,et al.Oxidative stress,a trigger of hepatitis C and B virus-induced liver carcinogenesis[J].Oncotarget,2017,8(3):3895-3932.
[21] BENDER D,HILDT E.Effect of hepatitis viruses on the Nrf2/Keap1-signaling pathway and its impact on viral replication and pathogenesis[J].Int J Mol Sci,2019,20(18):4659.
[22] IBRAHIM FG,AHMED KA.Curcumin ameliorates doxorubicin-induced cardiotoxicity and hepatotoxicity via suppressing oxidative stress and modulating iNOS,NF-κB,and TNF-α in rats[J].Cardiovasc Toxicol,2022,22(2):152-166.
[23] MILIARAKI M,BRIASSOULIS P,ILIA S,et al.Oxidant/antioxidant status is impaired in sepsis and is related to anti-apoptotic,inflammatory,and innate immunity alterations[J/OL].Antioxidants (Basel),2022,11(2):231[2022-03-30].https://doi.org/10.3390/antiox11020231.
[24] CIESLAR-POBUDA A,AHRENS TD,CAGLAYAN S,et al.DNMT3B deficiency alters mitochondrial biogenesis and α-ketoglutarate levels in human embryonic stem cells[J].Stem Cells,2020,38(11):1409-1422.
[25] PATIL V,CUENIN C,CHUNG F,et al.Human mitochondrial DNA is extensively methylated in a non-CpG context[J].Nucleic Acids Res,2019,47(19):10072-10085.
[26] IGUCHI E,TAKAI A,TAKEDA H,et al.DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis[J].Sci Rep,2020,10(1):21268.
[27] PAUDEL R,FUSI L,SCHMIDT M.The MEK5/ERK5 pathway in health and disease[J].Int J Mol Sci,2021,22(14):7594.
[28] DI BL,GAGLIARDI PA,PULIAFITO A,et al.Serine/threonine kinase 3-phosphoinositide-dependent protein kinase-1 (PDK1) as a key regulator of cell migration and cancer dissemination[J].Cancers(Basel),2017,9(3):25.

Memo

Memo:
四川省南充市市校合作科研专项(编号:18SXHZ0496);四川省南充市应用技术研究与开发资金项目(编号:20YFZJ0110)
Last Update: 1900-01-01